Velarion Records
Free. Unsubscribe any time.

Neurogene Inc. (NGNE)

Neurogene Inc. filed 6 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 2 reporting owners, covering 12 transactions and 37,594 shares. None carries the SEC's AFF10B5ONE flag; all 6 name a plan in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in Neurogene Inc. 12

Adoption dates in Neurogene Inc. 2

Results prints in Neurogene Inc. 0

Trades before a print in Neurogene Inc. 0

Interval to Neurogene Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Neurogene Inc. states

Filing text: “10b5-1 plan adopted by the reporting person on February 6, 2025”

Sources: SEC EDGAR full-text search and the SEC submissions API.